Bromobutoxyquinolinone Aripiperazole intermediate

3,4-Dihydro-7-(4-Bromobutoxy)-2(1H)-quinolinone is intermedite of Aripiperazole.Aripiprazole is a medication used to manage and treat schizophrenia, mania associated with bipolar I disorder, irritability associated with an autism spectrum disorder, disjunctive therapy in major depressive disorder, and Tourette syndrome About the Company GST Registration Date: 2019 Legal Status of Firm: Limited Company Number of Employees: Upto 10 People Annual Turnover: 40 L - 1.5 Cr company-description: Equilife Laboratories Pvt.Ltd.is pharmaceutical company with corporate origins in India.We provide innovative process development of pharmaceutical products and services to clients all over the world. Equilife Laboratories Private Limited team is Post-graduates in organic chemistry and Microbiology and have rich work experience with more than 19+ years in Research & development and manufacturing of various API at bulk scale. Our team is worked with pharmaceutical companies like Lupin Limited, Actavis pharma Pvt.Ltd, Unichem Impurities and Research institutes/organizations like National chemical laboratory (NCL-Pune), Indian Institute of Technology (IIT-Mumbai). On our record we have more than 10 patents and publication. We are experienced in optimization,scale up on various drug intermediates and drug substances like Anti-cancer (Oncology products), Anti-HIV, Anti-bacterial, Antibiotics, Anti-hepatitis, Anti-hypertensive, Anti-inflammatory, Anti-parkinson's, Anti-progesterone (oral contraceptives), Anti-depressant, Antipsychotic, Anti-viral, Anti-rheumatic and Diuretics. Equilife Laboratories Private Limited is established on 14th August 2019 at Pune, Maharashtra, India. Our R&D and Manufacturing facility is located at Pune, Maharashtra, India.